Phenotypic differences betweenDrosophilaAlzheimer’s disease models expressing humanAβ42in the developing eye and brain
Open Access
- 15 April 2017
- journal article
- research article
- Published by Taylor & Francis in Animal Cells and Systems
- Vol. 21 (3) , 160-168
Abstract
Drosophila melanogaster expressing amyloid-β42 (Aβ42) transgenes have been used as models to study Alzheimer’s disease. Various Aβ42 transgenes with different structures induce different phenotypes, which make it difficult to compare data among studies which use different transgenic lines. In this study, we compared the phenotypes of four frequently used Aβ42 transgenic lines, UAS-Aβ422X, UAS-Aβ42BL33770, UAS-Aβ4211C39, and UAS-Aβ42H29.3. Among the four transgenic lines, only UAS-Aβ422X has two copies of the upstream activation sequence-amyloid-β42 (UAS-Aβ42) transgene, while remaining three have one copy. UAS-Aβ42BL33770 has the 3′ untranslated region of Drosophila α-tubulin, while the others have that of SV40. UAS-Aβ4211C39 and UAS-Aβ42H29.3 have the rat pre-proenkephalin signal peptide, while UAS-Aβ422X and UAS-Aβ42BL33770 have that of the fly argos protein. When the transgenes were expressed ectopically in the developing eyes of the flies, UAS-Aβ422X transgene resulted in a strongly reduced and rough eye phenotype, while UAS-Aβ42BL33770 only showed a strong rough eye phenotype; UAS-Aβ42H29.3 and UAS-Aβ4211C39 had mild rough eyes. The levels of cell death and reactive oxygen species (ROS) in the eye imaginal discs were consistently the highest in UAS-Aβ422X, followed by UAS-Aβ42BL33770, UAS-Aβ4211C39, and UAS-Aβ42H29.3. Surprisingly, the reduction in survival during the development of these lines did not correlate with cell death or ROS levels. The flies which expressed UAS-Aβ4211C39 or UAS-Aβ42H29.3 experienced greatly reduced survival rates, although low levels of ROS or cell death were detected. Collectively, our results demonstrated that different Drosophila AD models show different phenotypic severity, and suggested that different transgenes may have different modes of cytotoxicity. Abbreviations: Aβ42: amyloid-β42; AD: Alzheimer’s disease; UAS: upstream activation sequenceKeywords
Funding Information
- Konkuk University (Konkuk University in 2014)
This publication has 47 references indexed in Scilit:
- Epidermal growth factor receptor is a preferred target for treating Amyloid-β–induced memory lossProceedings of the National Academy of Sciences, 2012
- Functional genomic screen and network analysis reveal novel modifiers of tauopathy dissociated from tau phosphorylationHuman Molecular Genetics, 2011
- The ER stress factor XBP1s prevents amyloid-β neurotoxicityHuman Molecular Genetics, 2011
- Tau Ser262 phosphorylation is critical for A 42-induced tau toxicity in a transgenic Drosophila model of Alzheimer's diseaseHuman Molecular Genetics, 2010
- PI3 kinase signaling is involved in Aβ-induced memory loss in DrosophilaProceedings of the National Academy of Sciences, 2010
- Distinctive roles of different β‐amyloid 42 aggregates in modulation of synaptic functionsThe FASEB Journal, 2009
- Cellular prion protein mediates impairment of synaptic plasticity by amyloid-β oligomersNature, 2009
- Overexpression of Neprilysin Reduces Alzheimer Amyloid-β42 (Aβ42)-induced Neuron Loss and Intraneuronal Aβ42 Deposits but Causes a Reduction in cAMP-responsive Element-binding Protein-mediated Transcription, Age-dependent Axon Pathology, and Premature Death in DrosophilaJournal of Biological Chemistry, 2008
- Pathways towards and away from Alzheimer's diseaseNature, 2004
- RAGE and amyloid-β peptide neurotoxicity in Alzheimer's diseaseNature, 1996